Literature DB >> 17254500

Mixed community-acquired lower respiratory tract infections.

Paolo Tarsia1, Stefano Aliberti, Maria Pappalettera, Francesco Blasi.   

Abstract

Although mixed infections are known to be clinically relevant in conditions such as nosocomial pneumonia and ventilator-related pneumonia, it is increasingly recognized that a substantial number of community-acquired lower respiratory tract infections may also be attributed to more than one pathogenic organism. A better definition of the true incidence of mixed infections in community-acquired lower respiratory tract infections is partly derived from recent advances in available diagnostic methods (eg, molecular biology). Two points still must be determined: whether the presence of a mixed infection is associated with altered outcomes and whether empirical antibiotic selection should be modified to account for potential polymicrobial infections.

Entities:  

Year:  2007        PMID: 17254500      PMCID: PMC7089415          DOI: 10.1007/s11908-007-0017-0

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  49 in total

1.  Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans.

Authors:  J Nordin; J Mullooly; S Poblete; R Strikas; R Petrucci; F Wei; B Rush; B Safirstein; D Wheeler; K L Nichol
Journal:  J Infect Dis       Date:  2001-08-09       Impact factor: 5.226

2.  Etiology and outcome of community-acquired pneumonia in patients with diabetes mellitus.

Authors:  Miquel Falguera; Ricard Pifarre; Antonio Martin; Anas Sheikh; Anna Moreno
Journal:  Chest       Date:  2005-11       Impact factor: 9.410

Review 3.  Monotherapy versus combination antimicrobial therapy for pneumococcal pneumonia.

Authors:  Grant W Waterer
Journal:  Curr Opin Infect Dis       Date:  2005-04       Impact factor: 4.915

Review 4.  Bacterial pneumonia. Managing a deadly complication of influenza in older adults with comorbid disease.

Authors:  Sanjay Sethi
Journal:  Geriatrics       Date:  2002-03

5.  Influenza A community-acquired pneumonia in East London infants and young children.

Authors:  Matthew Laundy; Ekundayo Ajayi-Obe; Khidir Hawrami; Celia Aitken; Judith Breuer; Robert Booy
Journal:  Pediatr Infect Dis J       Date:  2003-10       Impact factor: 2.129

6.  Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor.

Authors:  Jonathan A McCullers; Jerold E Rehg
Journal:  J Infect Dis       Date:  2002-07-10       Impact factor: 5.226

7.  Chlamydia species as a cause of community-acquired pneumonia in Canada.

Authors:  T J Marrie; R W Peeling; T Reid; E De Carolis
Journal:  Eur Respir J       Date:  2003-05       Impact factor: 16.671

8.  Microbiological etiology in clinically diagnosed community-acquired pneumonia in primary care in Orebro, Sweden.

Authors:  F Lagerström; M Bader; M Foldevi; H Fredlund; I Nordin-Olsson; H Holmberg
Journal:  Clin Microbiol Infect       Date:  2003-07       Impact factor: 8.067

9.  Improved diagnosis of the etiology of community-acquired pneumonia with real-time polymerase chain reaction.

Authors:  Kate E Templeton; Sitha A Scheltinga; Willian C J F M van den Eeden; A Willy Graffelman; Peterhans J van den Broek; Eric C J Claas
Journal:  Clin Infect Dis       Date:  2005-06-22       Impact factor: 9.079

10.  Etiology of community-acquired pneumonia in hospitalized school-age children: evidence for high prevalence of viral infections.

Authors:  M N Tsolia; S Psarras; A Bossios; H Audi; M Paldanius; D Gourgiotis; K Kallergi; D A Kafetzis; A Constantopoulos; N G Papadopoulos
Journal:  Clin Infect Dis       Date:  2004-08-13       Impact factor: 9.079

View more
  6 in total

Review 1.  Polymicrobial interactions: impact on pathogenesis and human disease.

Authors:  Brian M Peters; Mary Ann Jabra-Rizk; Graeme A O'May; J William Costerton; Mark E Shirtliff
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

2.  Modelling the bacterial communities associated with cystic fibrosis lung infections.

Authors:  T Spasenovski; M P Carroll; A K Lilley; M S Payne; K D Bruce
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-01-23       Impact factor: 3.267

Review 3.  Vaccine development in Staphylococcus aureus: taking the biofilm phenotype into consideration.

Authors:  Janette M Harro; Brian M Peters; Graeme A O'May; Nathan Archer; Patrick Kerns; Ranjani Prabhakara; Mark E Shirtliff
Journal:  FEMS Immunol Med Microbiol       Date:  2010-05-29

4.  Pneumonia and Pleural Empyema due to a Mixed Lactobacillus spp. Infection as a Possible Early Esophageal Carcinoma Signature.

Authors:  Eleftheria Chaini; Nikolaos D Chainis; Anastasios Ioannidis; Maria Magana; Chryssoula Nikolaou; Joseph Papaparaskevas; Melina-Vassiliki Liakata; Panagiotis Katopodis; Leonidas Papastavrou; George P Tegos; Stylianos Chatzipanagiotou
Journal:  Front Med (Lausanne)       Date:  2016-09-28

Review 5.  Biomarkers of Community-Acquired Pneumonia: A Key to Disease Diagnosis and Management.

Authors:  Elena N Savvateeva; Alla Yu Rubina; Dmitry A Gryadunov
Journal:  Biomed Res Int       Date:  2019-04-30       Impact factor: 3.411

6.  Causes of Lower Respiratory Tract Infections and the Use of Diagnostic Biomarkers in Blood Samples from Children in Hohhot, Inner Mongolia, China, Between July 2019 and June 2020.

Authors:  Yanzi Gan; YuWei Hu; Hairong Dong; Lina Wu; Yan Niu
Journal:  Med Sci Monit       Date:  2022-03-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.